<DOC>
	<DOCNO>NCT00585689</DOCNO>
	<brief_summary>Study participant diagnose bladder cancer invade muscle wall bladder . Surgery use remove cancer muscle bladder . Unfortunately , approximately 50 % people may cancer return another location . For reason , researcher focus new chemotherapy regimen give surgery ( remove bladder ) may decrease likelihood cancer spread . Paclitaxel , carboplatin gemcitabine chemotherapy drug know destroy bladder cancer cell . ABI-007 ( brand name Abraxaneâ„¢ ) form chemotherapy drug call paclitaxel . Standard paclitaxel formulate ethanol substance call Cremophor EL ( polyoxyethylated castor oil ) . However , additive felt contribute side effect ( possibly severe ) associate paclitaxel . ABI-007 contain additive may deliver drug tumor cell . ABI-007 approve United States Food Drug Administration ( FDA ) treatment metastatic ( advanced ) breast cancer , evaluate cancer research study . This study evaluate safety efficacy combination ABI-007 , carboplatin gemcitabine treatment bladder cancer prior surgery remove bladder .</brief_summary>
	<brief_title>Neoadjuvant ABI-007 , Carboplatin Gemcitabine Locally Advanced Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Histologically prove locally advanced ( T24 , N0 , M0 Tany , N13 , M0 ) urothelial carcinoma bladder candidate cystectomy follow chemotherapy . Tumor specimen must available assay molecular marker ( correlative research ) . Performance status 0 , 1 2 Eastern Cooperative Oncology Group ( ECOG ) criterion . Serum creatinine &lt; 2.0 mg/dl and/or creatinine clearance &gt; 40 ml/min . Granulocyte count &gt; 1,500/mm3 , platelet &gt; 100,000/mm3 , hemoglobin &gt; 9.0 g/dl . Adequate liver function : AST ALT &lt; 2.5 X upper limit normal , alkaline phosphatase &lt; 2.5 X upper limit normal , bilirubin &lt; 1.5 mg/dl . Preexisting peripheral neuropathy &gt; grade 2 Recovered effect surgery . Women/men reproductive potential may participate unless agree use effective contraceptive method . Women reproductive potential must negative pregnancy test . Prior systemic intraarterial chemotherapy rior radiotherapy . ( intravesical chemotherapy allow . ) Preexisting peripheral neuropathy &gt; grade 2 Prior malignancy [ except adequately treat basal cell ( squamous cell ) skin cancer , situ cervical cancer cancer patient disease free 2 year ] Unresolved bacterial infection require active treatment antibiotic . ( Treatment may begin conclusion antibiotic therapy . ) Pregnant lactate woman may participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Locally advanced urothelial carcinoma bladder</keyword>
</DOC>